Kidswell Bio Corporation (4584.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−33.3x

Market Cap

JPY 7.99B

MomentumView details →

1D Return

−3.59%

YTD Return

−19.21%

RSI (14)

50.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−33.3x

Market Cap

JPY 7.99B

RSI (14)

50.5

MomentumView details →

1D Return

−3.59%

YTD Return

−19.21%

ProfitabilityView details →

Gross Margin

23.22%

Net Margin

0.34%

EBITDA Margin

0.39%

ROE (TTM)

1.25%

ROA (TTM)

0.38%

Asset Turnover

1.16x

GrowthView details →

Revenue YoY

+81.08%

EPS YoY

+105.13%

FCF YoY

—

Revenue CAGR 3Y

+47.96%

EPS CAGR 3Y

+98.71%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.30x

Current Ratio

3.07x

Quick Ratio

2.76x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

7.06B

Net Income (TTM)

24.00M

Op. CF (TTM)

—

Next earningsNov 11, 2026 →

Latest newsMore news →

Kids Well Bio announced that its subsidiary S-Quatre, in collaboration with Nagoya University, completed a clinical study on cerebral palsy treatment using stem cells derived from baby teeth, with an independent safety evaluation committee confirming safety throughout the observation period.22d ago

Kids Well Bio announced its first-quarter results for April-June 2026, with consolidated ordinary profit rising 16.0% year-on-year to 200 million yen.23d ago

Similar companies

OncoTherapy Science,Inc.4564.T Carna Biosciences,Inc.4572.T Tsubota Laboratory Incorporated4890.T Nano Holdings,Inc.4571.T MORISHITA JINTAN CO.,LTD.4524.T Solasia Pharma K.K.4597.T Find similar companies →

Latest newsMore news →

Kids Well Bio announced that its subsidiary S-Quatre, in collaboration with Nagoya University, completed a clinical study on cerebral palsy treatment using stem cells derived from baby teeth, with an independent safety evaluation committee confirming safety throughout the observation period.22d ago Kids Well Bio announced its first-quarter results for April-June 2026, with consolidated ordinary profit rising 16.0% year-on-year to 200 million yen.23d ago